BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23785238)

  • 1. The cost of schizophrenia in Japan.
    Sado M; Inagaki A; Koreki A; Knapp M; Kissane LA; Mimura M; Yoshimura K
    Neuropsychiatr Dis Treat; 2013; 9():787-98. PubMed ID: 23785238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of anxiety disorders in Japan in 2008: a prevalence-based approach.
    Sado M; Takechi S; Inagaki A; Fujisawa D; Koreki A; Mimura M; Yoshimura K
    BMC Psychiatry; 2013 Dec; 13():338. PubMed ID: 24350841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The estimated cost of dementia in Japan, the most aged society in the world.
    Sado M; Ninomiya A; Shikimoto R; Ikeda B; Baba T; Yoshimura K; Mimura M
    PLoS One; 2018; 13(11):e0206508. PubMed ID: 30418983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost of depression among adults in Japan in 2005.
    Sado M; Yamauchi K; Kawakami N; Ono Y; Furukawa TA; Tsuchiya M; Tajima M; Kashima H; ; Nakane Y; Nakamura Y; Fukao A; Horiguchi I; Tachimori H; Iwata N; Uda H; Nakane H; Watanabe M; Oorui M; Funayama K; Naganuma Y; Hata Y; Kobayashi M; Ahiko T; Yamamoto Y; Takeshima T; Kikkawa T
    Psychiatry Clin Neurosci; 2011 Aug; 65(5):442-50. PubMed ID: 21851453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social burden of three major diseases in Japan: A time trend and future projections using the comprehensive cost of illness method.
    Hirata K; Matsumoto K; Hatakeyama Y; Onishi R; Seto K; Hasegawa T
    PLoS One; 2023; 18(1):e0280311. PubMed ID: 36630469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Economic Burden of Schizophrenia in the United States.
    Kadakia A; Catillon M; Fan Q; Williams GR; Marden JR; Anderson A; Kirson N; Dembek C
    J Clin Psychiatry; 2022 Oct; 83(6):. PubMed ID: 36244006
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost of schizophrenia in England.
    Mangalore R; Knapp M
    J Ment Health Policy Econ; 2007 Mar; 10(1):23-41. PubMed ID: 17417045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression: cost-of-illness studies in the international literature, a review.
    Berto P; D'Ilario D; Ruffo P; Di Virgilio R; Rizzo F
    J Ment Health Policy Econ; 2000 Mar; 3(1):3-10. PubMed ID: 11967432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Socioeconomic burden of schizophrenia: a targeted literature review of types of costs and associated drivers across 10 countries.
    Kotzeva A; Mittal D; Desai S; Judge D; Samanta K
    J Med Econ; 2023; 26(1):70-83. PubMed ID: 36503357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic Burden of Alzheimer's Disease Dementia in Japan.
    Ikeda S; Mimura M; Ikeda M; Wada-Isoe K; Azuma M; Inoue S; Tomita K
    J Alzheimers Dis; 2021; 81(1):309-319. PubMed ID: 33780371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
    Phanthunane P; Whiteford H; Vos T; Bertram M
    J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The economic burden of schizophrenia in the United States in 2002.
    Wu EQ; Birnbaum HG; Shi L; Ball DE; Kessler RC; Moulis M; Aggarwal J
    J Clin Psychiatry; 2005 Sep; 66(9):1122-9. PubMed ID: 16187769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Productivity and deadweight losses due to relapses of schizophrenia in Japan.
    Nakamura Y; Mahlich J
    Neuropsychiatr Dis Treat; 2017; 13():1341-1348. PubMed ID: 28553120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The societal cost of schizophrenia in Sweden.
    Ekman M; Granstrom O; Omerov S; Jacob J; Landen M
    J Ment Health Policy Econ; 2013 Mar; 16(1):13-25. PubMed ID: 23676412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost of disorders of the brain in Europe 2010.
    Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J;
    Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct economic burden of mental health disorders associated with polycystic ovary syndrome: Systematic review and meta-analysis.
    Yadav S; Delau O; Bonner AJ; Markovic D; Patterson W; Ottey S; Buyalos RP; Azziz R
    Elife; 2023 Aug; 12():. PubMed ID: 37534878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Economic Burden of Schizophrenia in the United States in 2013.
    Cloutier M; Aigbogun MS; Guerin A; Nitulescu R; Ramanakumar AV; Kamat SA; DeLucia M; Duffy R; Legacy SN; Henderson C; Francois C; Wu E
    J Clin Psychiatry; 2016 Jun; 77(6):764-71. PubMed ID: 27135986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of Prostate Cancer Cost in Egypt From a Societal Perspective.
    Elsisi GH; El-Attar MM; Ismaeil SM; El-Shater ME; Kirollos MG; Sedrak AS; Morad H; Abdel-Mohsen H; Abdel-Aziz M; Magdy M; Loutfy O
    Glob J Qual Saf Healthc; 2023 May; 6(2):33-41. PubMed ID: 37333760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost of depression in Europe.
    Sobocki P; Jönsson B; Angst J; Rehnberg C
    J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive cost of illness of dementia in Japan: a time trend analysis based on Japanese official statistics.
    Hanaoka S; Matsumoto K; Kitazawa T; Fujita S; Seto K; Hasegawa T
    Int J Qual Health Care; 2019 Apr; 31(3):231-237. PubMed ID: 30272131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.